Posttransplant biliary complications in the pre- and post-model for end-stage liver disease era
β Scribed by Vinay Sundaram; Deborah T. Jones; Nilesh H. Shah; Michael E. de Vera; Paulo Fontes; J. Wallis Marsh; Abhinav Humar; Jawad Ahmad
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 148 KB
- Volume
- 17
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.22251
No coin nor oath required. For personal study only.
β¦ Synopsis
Biliary complications remain a cause of morbidity after liver transplantation. The aim of this study was to determine whether changes in clinical practice in the era of the Model for End-Stage Liver Disease (MELD) has affected biliary complications after liver transplantation. We retrospectively reviewed all deceased donor liver transplants at a single center. Patients were categorized as pre-or post-MELD (transplant before or after February 28, 2002). A total of 1798 recipients underwent deceased donor liver transplants. Biliary stricture was more common in the post-MELD era (15.4% versus 6.4%, P < 0.001). The strongest risk factors for stricture development were donor age (odds ratio [OR] ΒΌ 1.01), presence of a prior bile leak (OR ΒΌ 2.24), use of choledochocholedochostomy (OR ΒΌ 2.22), and the post-MELD era (OR ΒΌ 2.30). Bile leak was more common in the pre-MELD era (7.5% versus 4.9%, P ΒΌ 0.02), with use of a T-tube as the strongest risk factor (OR ΒΌ 3.38). Surgical factors did not influence the biliary complication rate. In conclusion, even when employing multivariate analysis to allow for factors that may influence biliary strictures, transplant in the post-MELD era was an independent predictor for stricture development. Further studies are warranted to determine the etiology of this increase.
π SIMILAR VOLUMES
Biliary complications remain a significant problem following liver transplantation in the Model for End-Stage Liver Disease (MELD) era. We hypothesized that donor, recipient, and technical variables may differentially affect anastomotic biliary complications in MELD era liver transplants. We reviewe
It has been suggested that hepatitis C virus (HCV) patients with hepatocellular carcinoma (HCC) may have worse outcomes after liver transplantation (LT) because of more aggressive tumor biology. In this study, we determined the post-LT survival of HCC patients with and without HCV using United Netwo
The proportion of patients undergoing liver transplantation (LT) with renal insufficiency has significantly increased in the Model for End-Stage Liver Disease (MELD) era. This study was designed to determine the incidence and predictors of post-LT chronic renal failure (CRF) and its effect on patien